Wei Lin

Insider Reports History

Entity
Individual
Location
C/O Erasca, Inc., 10835 Road To The Cure, Suite 140, San Diego, California
Signature
/s/ Jack Anders, as Attorney-in-fact for Wei Lin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wei Lin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revolution Medicines, Inc. Chief Medical Officer Common Stock 70.9K $2.65M $37.39 Jun 17, 2024 Direct
Erasca, Inc. Chief Medical Officer Common Stock 316K $502K $1.59 Feb 1, 2023 Direct
2seventy bio, Inc. Director Common Stock 32.9K $137K $4.18 Jun 10, 2024 Direct
2seventy bio, Inc. Director Stock Options (Right to buy) 24.1K $94.7K $3.93 Jun 10, 2024 Direct
Erasca, Inc. Chief Medical Officer Stock Option (right to buy) 560K Feb 1, 2023 Direct

Insider Reports Filed by Wei Lin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVMD Revolution Medicines, Inc. Jun 17, 2024 1 -$209K 4 Jun 20, 2024 Chief Medical Officer
TSVT 2seventy bio, Inc. Jun 10, 2024 2 $0 4 Jun 12, 2024 Director
RVMD Revolution Medicines, Inc. Mar 21, 2024 0 $0 3 Mar 29, 2024 Chief Medical Officer
TSVT 2seventy bio, Inc. Jun 13, 2023 2 $0 4 Jun 15, 2023 Director
TSVT 2seventy bio, Inc. Mar 7, 2023 2 $0 4 Mar 9, 2023 Director
TSVT 2seventy bio, Inc. Mar 7, 2023 0 $0 3 Mar 9, 2023 Director
ERAS Erasca, Inc. Feb 1, 2023 3 $7.17K 4 Feb 3, 2023 Chief Medical Officer
ERAS Erasca, Inc. Feb 1, 2022 2 $18.1K 4 Feb 3, 2022 Chief Medical Officer
ERAS Erasca, Inc. Jul 15, 2021 0 $0 3 Jul 15, 2021 Chief Medical Officer